Logo image of NLOP

NET LEASE OFFICE PROPERTY (NLOP) Stock Fundamental Analysis

NYSE:NLOP - New York Stock Exchange, Inc. - US64110Y1082 - REIT - Currency: USD

31.29  -0.01 (-0.03%)

After market: 31.29 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NLOP. NLOP was compared to 129 industry peers in the Diversified REITs industry. While NLOP seems to be doing ok healthwise, there are quite some concerns on its profitability. NLOP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year NLOP has reported negative net income.
In the past year NLOP had a positive cash flow from operations.
In multiple years NLOP reported negative net income over the last 5 years.
NLOP had a positive operating cash flow in each of the past 5 years.
NLOP Yearly Net Income VS EBIT VS OCF VS FCFNLOP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

NLOP has a Return On Assets of -8.05%. This is amonst the worse of the industry: NLOP underperforms 92.25% of its industry peers.
With a Return On Equity value of -10.85%, NLOP is not doing good in the industry: 78.29% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 3.02%, NLOP perfoms like the industry average, outperforming 58.91% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for NLOP is in line with the industry average of 3.15%.
The last Return On Invested Capital (3.02%) for NLOP is above the 3 year average (2.84%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -8.05%
ROE -10.85%
ROIC 3.02%
ROA(3y)-6.79%
ROA(5y)-3.86%
ROE(3y)-11.26%
ROE(5y)-6.42%
ROIC(3y)2.84%
ROIC(5y)2.82%
NLOP Yearly ROA, ROE, ROICNLOP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -5 -10 -15

1.3 Margins

Looking at the Operating Margin, with a value of 22.23%, NLOP is in line with its industry, outperforming 49.61% of the companies in the same industry.
In the last couple of years the Operating Margin of NLOP has declined.
NLOP has a Gross Margin of 66.05%. This is comparable to the rest of the industry: NLOP outperforms 48.84% of its industry peers.
In the last couple of years the Gross Margin of NLOP has declined.
Industry RankSector Rank
OM 22.23%
PM (TTM) N/A
GM 66.05%
OM growth 3Y-9.93%
OM growth 5Y-6.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.53%
GM growth 5Y-2.94%
NLOP Yearly Profit, Operating, Gross MarginsNLOP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

NLOP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for NLOP remains at a similar level compared to 1 year ago.
Compared to 1 year ago, NLOP has an improved debt to assets ratio.
NLOP Yearly Shares OutstandingNLOP Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M
NLOP Yearly Total Debt VS Total AssetsNLOP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.22, we must say that NLOP is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.22, NLOP belongs to the top of the industry, outperforming 85.27% of the companies in the same industry.
NLOP has a debt to FCF ratio of 2.89. This is a good value and a sign of high solvency as NLOP would need 2.89 years to pay back of all of its debts.
The Debt to FCF ratio of NLOP (2.89) is better than 99.22% of its industry peers.
NLOP has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
NLOP has a Debt to Equity ratio of 0.26. This is amongst the best in the industry. NLOP outperforms 97.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 2.89
Altman-Z 1.22
ROIC/WACC0.43
WACC7.03%
NLOP Yearly LT Debt VS Equity VS FCFNLOP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

NLOP has a Current Ratio of 0.65. This is a bad value and indicates that NLOP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.65, NLOP is doing worse than 68.99% of the companies in the same industry.
NLOP has a Quick Ratio of 0.65. This is a bad value and indicates that NLOP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.65, NLOP is doing worse than 68.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.65
Quick Ratio 0.65
NLOP Yearly Current Assets VS Current LiabilitesNLOP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 60.71% over the past year.
Looking at the last year, NLOP shows a very negative growth in Revenue. The Revenue has decreased by -41.80% in the last year.
Measured over the past years, NLOP shows a decrease in Revenue. The Revenue has been decreasing by -4.00% on average per year.
EPS 1Y (TTM)60.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.76%
Revenue 1Y (TTM)-41.8%
Revenue growth 3Y-1.29%
Revenue growth 5Y-4%
Sales Q2Q%-33.62%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NLOP Yearly Revenue VS EstimatesNLOP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 50M 100M 150M

2

4. Valuation

4.1 Price/Earnings Ratio

NLOP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NLOP Price Earnings VS Forward Price EarningsNLOP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NLOP indicates a rather cheap valuation: NLOP is cheaper than 100.00% of the companies listed in the same industry.
91.47% of the companies in the same industry are more expensive than NLOP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.01
EV/EBITDA 5.84
NLOP Per share dataNLOP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NLOP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NET LEASE OFFICE PROPERTY

NYSE:NLOP (5/29/2025, 4:15:01 PM)

After market: 31.29 0 (0%)

31.29

-0.01 (-0.03%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners69.49%
Inst Owner Change-16.74%
Ins Owners0.53%
Ins Owner Change0%
Market Cap463.40M
Analysts82.86
Price Target46.92 (49.95%)
Short Float %1.86%
Short Ratio2.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.64
P/FCF 9.01
P/OCF 7.78
P/B 0.8
P/tB 0.8
EV/EBITDA 5.84
EPS(TTM)-4.27
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.47
FCFY11.1%
OCF(TTM)4.02
OCFY12.86%
SpS8.61
BVpS39.31
TBVpS39.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.05%
ROE -10.85%
ROCE 3.83%
ROIC 3.02%
ROICexc 3.14%
ROICexgc 3.26%
OM 22.23%
PM (TTM) N/A
GM 66.05%
FCFM 40.37%
ROA(3y)-6.79%
ROA(5y)-3.86%
ROE(3y)-11.26%
ROE(5y)-6.42%
ROIC(3y)2.84%
ROIC(5y)2.82%
ROICexc(3y)2.9%
ROICexc(5y)2.86%
ROICexgc(3y)3.06%
ROICexgc(5y)3.06%
ROCE(3y)3.6%
ROCE(5y)3.57%
ROICexcg growth 3Y3.88%
ROICexcg growth 5YN/A
ROICexc growth 3Y5.46%
ROICexc growth 5YN/A
OM growth 3Y-9.93%
OM growth 5Y-6.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.53%
GM growth 5Y-2.94%
F-Score4
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 2.89
Debt/EBITDA 1.49
Cap/Depr 11.34%
Cap/Sales 6.38%
Interest Coverage 250
Cash Conversion 59.59%
Profit Quality N/A
Current Ratio 0.65
Quick Ratio 0.65
Altman-Z 1.22
F-Score4
WACC7.03%
ROIC/WACC0.43
Cap/Depr(3y)22.59%
Cap/Depr(5y)16.46%
Cap/Sales(3y)10.42%
Cap/Sales(5y)7.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.76%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-41.8%
Revenue growth 3Y-1.29%
Revenue growth 5Y-4%
Sales Q2Q%-33.62%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.47%
EBIT growth 3Y-11.09%
EBIT growth 5Y-10.12%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.09%
FCF growth 3Y-5.6%
FCF growth 5Y27.04%
OCF growth 1Y1.26%
OCF growth 3Y-1.56%
OCF growth 5Y-2.85%